当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析

金城医药

(300233)

  

流通市值:61.12亿  总市值:63.38亿
流通股本:3.70亿   总股本:3.84亿

金城医药(300233)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.89亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益381893.40万元,未分配利润92121.92万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产590050.38万元,负债208156.97万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入931,696,552.763,538,312,459.652,568,752,667.571,705,293,296.69
营业总成本824,597,996.183,293,667,808.572,386,749,531.41,570,483,289.96
营业利润115,649,572.17225,849,216.89175,516,338.76134,174,184.2
利润总额115,554,756.31225,407,539.95176,301,377.39135,692,352.55
净利润89,158,928.05193,310,999.11146,655,023.18110,772,560.85
其他综合收益-1,705,202.587,056,674.17,056,674.1
综合收益总额89,158,928.05195,016,201.69153,711,697.28117,829,234.95
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,370,818,641.242,369,280,812.572,417,085,595.082,295,705,478.95
非流动资产合计3,529,685,124.533,546,798,516.243,528,234,800.043,541,542,485.36
资产总计5,900,503,765.775,916,079,328.815,945,320,395.125,837,247,964.31
流动负债合计1,510,537,434.681,600,325,890.831,608,234,932.211,612,252,564.04
非流动负债合计571,032,281.54534,693,997.24594,314,425.85492,953,583.33
负债合计2,081,569,716.222,135,019,888.072,202,549,358.062,105,206,147.37
归属于母公司股东权益合计3,744,616,592.633,714,133,643.743,680,271,565.753,674,083,382.61
股东权益合计3,818,934,049.553,781,059,440.743,742,771,037.063,732,041,816.94
负债和股东权益合计5,900,503,765.775,916,079,328.815,945,320,395.125,837,247,964.31
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计908,762,226.033,330,709,544.092,407,494,163.591,629,474,458.67
经营活动现金流出小计867,389,029.392,666,634,411.281,946,573,132.531,348,090,746.37
经营活动产生的现金流量净额41,373,196.64664,075,132.81460,921,031.06281,383,712.3
投资活动现金流入小计96,694,101187,148,157.2190,021,568.5681,089,169.26
投资活动现金流出小计148,109,225.66497,136,919.57347,388,185.51210,416,118.21
投资活动产生的现金流量净额-51,415,124.66-309,988,762.37-157,366,616.95-129,326,948.95
筹资活动现金流入小计190,000,000348,368,315.6328,562,071.6216,662,071.6
筹资活动现金流出小计164,248,733.14591,679,151.28421,901,047.08309,430,906.41
筹资活动产生的现金流量净额25,751,266.86-243,310,835.68-93,338,975.48-92,768,834.81
汇率变动对现金及现金等价物的影响1,270,711.153,466,169.142,502,903.951,341,941.84
现金及现金等价物净增加额16,980,049.99114,241,703.9212,718,342.5860,629,870.38
期末现金及现金等价物余额921,001,178.3904,021,128.311,002,497,766.99850,409,294.79
TOP↑